News
Romiplostim’s approval was based on the results of a phase-3 trial published in 2008 in The Lancet. The trial included two parallel studies; one enrolled splenectomized patients, and the other ...
The rate of a platelet response in the romiplostim group was 2.3 times that in the standard-of-care group (95% confidence interval [CI], 2.0 to 2.6; P<0.001). Patients receiving romiplostim had a ...
Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...
5d
Clinical Trials Arena on MSNASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaeniaNplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.
June 12, 2009 (Berlin, Germany) — The platelet-stimulating drug romiplostim (Nplate) prevents a significant number of splenectomies in patients with immune thrombocytopenia (ITP), according to ...
Purpose: The pharmacology, pharmacokinetics, dosage and administration, efficacy, safety, effects on quality of life, and place in therapy of romiplostim are reviewed. Summary: Romiplostim is a ...
Newer second-generation thrombopoietin analogs, romiplostim (NPlate, Amgen) and eltrombopag (Promacta/Revolade, GlaxoSmithKline), have been developed. These agents stimulate the thrombopoietin ...
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study We conducted a phase II randomized trial ...
Nplate (romiplostim) is a prescription drug that’s used to increase a low platelet count caused by certain conditions. Nplate comes as a powder that’s mixed with liquid and given as an injecti ...
SAN DIEGO, CA—Long-term use of romiplostim in myelodysplastic syndrome (MDS) patients for up to 3.5 years (five years including therapy on prior studies) produced platelet responses in 83% of ...
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Nplate ...
Nplate (romiplostim) injection is a prescription drug that’s used to treat low platelet counts. Nplate’s cost may depend on factors such as your dosage, whether you have health insurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results